共 4 条
[1]
PRS-03: Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).[J].Giorgio Scagliotti;Parikh Purvish;Joachim von Pawel;Bonne Biesma;Johan Vansteenkiste;Christian Manegold;Lorinda Simms;Katherine Posther Sugarman;Coleman Obasaju;Johannes Blatter.Journal of Thoracic Oncology.2007, 8S
[2]
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase
[J].
CANCER,
2006, 107 (07)
:1589-1596
Ceppi, Paolo
;
Volante, Marco
;
Saviozzi, Silvia
;
Rapa, Ida
;
Novello, Silvia
;
Cambieri, Alberto
;
Lo Iacono, Marco
;
Cappia, Susanna
;
Papotti, Mauro
;
Scagliotti, Giorgio V.
.
[3]
P-479 Expression of class III beta tubulin is predictive of patientoutcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.[J].C. Dumontet;P. Seve;S. Isaac;O. Tredan;P. Souquet;Y. Pacheco;M. Perol;L. Lafanéchère;A. Penet;E. Peiller.Lung Cancer.2005,
[4]
A prognostic model based on BRCA1 mRNA expression:a new determinant of outcome in early non-small-cell lung cancer..Rosell CR;Jassem E;Skrzypski M;et al;.Euro J Cancer.2007, 04